|SEQ_NO||1||Date of announcement||2020/09/10||Time of announcement||15:13:34|
|Subject||Announcement of TTY Biopharm's unaudited income information in August 2020|
|Date of events||2020/09/10||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2020/09/10
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $302,717 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $38,867 thousands, and a consolidated income before tax of $51,183 thousands in August 2020; net income attributed to stockholders of the company was $43,166 thousands; EPS is $0.17.
Year-to-date consolidated net sales was $2,610,415 thousands (in NT dollars; unaudited), a consolidated operating profit was $603,528 thousands and consolidated income before tax was $683,702 thousands until August 2020; year-to-date net income attributed to stockholders of the company was $541,478 thousands; EPS is $2.18.
7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.